HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
